Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a ful l
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03564444” into
the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D2560C00015” into the search box, and click “Find a Study”.
Full Study Title: A Phase 4, Randomized, Double-blind, Placebo-controlled Study
to Evaluate the Safety of 2 New 6:2 Influenza Virus Reassortants inA dults
National Clinical Trials number: NCT03564444
MedImmune Protocol Number: D2560C00015
MedImmune, LLC, a member of the AstraZeneca Group, sponsored this study and
has its headquarters at One MedImmune Way, Gaithersburg, MD 20837 USA.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part i n
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version 1.0 2020_01_21